Thomas Morgan - DHC Acquisition CoChief Officer
| DHCAUDelisted Stock | USD 10.25 0.00 0.00% |
Insider
Thomas Morgan is CoChief Officer of DHC Acquisition Corp
| Age | 62 |
| Phone | 310 228 2894 |
| Web | https://www.dhcacquisition.partners |
Thomas Morgan Latest Insider Activity
Tracking and analyzing the buying and selling activities of Thomas Morgan against DHC Acquisition stock is an integral part of due diligence when investing in DHC Acquisition. Thomas Morgan insider activity provides valuable insight into whether DHC Acquisition is net buyers or sellers over its current business cycle. Note, DHC Acquisition insiders must abide by specific rules, including filing SEC forms every time they buy or sell DHC Acquisition'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Thomas Morgan over three months ago Acquisition by Thomas Morgan of 27316 shares of Rayonier Advanced subject to Rule 16b-3 |
DHC Acquisition Management Efficiency
The company has return on total asset (ROA) of (0.0114) % which means that it has lost $0.0114 on every $100 spent on assets. This is way below average. DHC Acquisition's management efficiency ratios could be used to measure how well DHC Acquisition manages its routine affairs as well as how well it operates its assets and liabilities.DHC Acquisition Corp has accumulated 123.78 K in total debt with debt to equity ratio (D/E) of 0.02, which may suggest the company is not taking enough advantage from borrowing. DHC Acquisition Corp has a current ratio of 0.27, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about DHC Acquisition's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| MD MA | Mind Medicine | 44 | |
| David Grainger | Centessa Pharmaceuticals PLC | 55 | |
| Schond Greenway | Mind Medicine | 52 | |
| Dianne MSW | Tarsus Pharmaceuticals | 47 | |
| Elizabeth MD | Tarsus Pharmaceuticals | 46 | |
| Tia Bush | Centessa Pharmaceuticals PLC | 53 | |
| Kimberly Ha | Mink Therapeutics | N/A | |
| David Chao | Centessa Pharmaceuticals PLC | 56 | |
| Kimia Keshtbod | Ardelyx | N/A | |
| Michael Ackermann | Tarsus Pharmaceuticals | 42 | |
| Marcus Dijk | Mink Therapeutics | 62 | |
| Iqbal LLB | Centessa Pharmaceuticals PLC | 43 | |
| Karen Anderson | Centessa Pharmaceuticals PLC | 56 | |
| Jrg Breitkopf | Sellas Life Sciences | N/A | |
| Dan Pavicich | Ardelyx | N/A | |
| MBA MD | Centessa Pharmaceuticals PLC | 51 | |
| Barbara Wood | Sellas Life Sciences | 61 | |
| MD MSc | Centessa Pharmaceuticals PLC | 64 | |
| Leonard JD | Tarsus Pharmaceuticals | 48 | |
| Scott MD | Mind Medicine | 67 | |
| Patrick MBA | Mink Therapeutics | N/A | |
Management Performance
| Return On Asset | -0.0114 |
DHC Acquisition Corp Leadership Team
Elected by the shareholders, the DHC Acquisition's board of directors comprises two types of representatives: DHC Acquisition inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DHC. The board's role is to monitor DHC Acquisition's management team and ensure that shareholders' interests are well served. DHC Acquisition's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DHC Acquisition's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Gaertner, CFO CoCEO | ||
| Thomas Morgan, CoChief Officer |
DHC Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DHC Acquisition a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.0114 | |||
| Current Valuation | 102.92 M | |||
| Price To Earning | 41.50 X | |||
| EBITDA | (13.53 M) | |||
| Net Income | 3.5 M | |||
| Cash And Equivalents | 405.64 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 123.78 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 0.28 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in DHC Stock
If you are still planning to invest in DHC Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DHC Acquisition's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |